Asia-Pacific Journal of Clinical Oncology

Papers
(The TQCC of Asia-Pacific Journal of Clinical Oncology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
40
Author List24
Unmet Need for Breast Cancer Screening Among South Asian Women in Victoria22
Serum miR‐146a level is a potential biomarker in predicting the outcome of diffuse large B‐cell lymphoma18
Issue Information15
Primary concurrent chemoradiation therapy with triweekly cisplatin as a standard protocol in patients aged ≥65 years with head and neck squamous cell carcinoma15
Retrospective review of safety and efficacy of anlotinib in advanced osteosarcoma with metastases after failure of standard multimodal therapy14
Issue Information13
The Best of the Best Oral Abstracts13
Highlighted Lectures and Awards 202212
Impact of incorporating Magnetic Resonance Imaging in FIGO Staging of Primary Carcinoma Cervix: Experience from a tertiary cancer center12
Poster Abstracts11
Neo‐adjuvant FOLFIRINOX in borderline resectable and locally advanced pancreatic adenocarcinoma10
TNT: Raising more questions than answers?10
Taxane‐based versus platinum‐based chemotherapy in early recurrent gastric cancer after radical surgery with S‐1 adjuvant chemotherapy: A multi‐institutional retrospective analysis10
Regorafenib outcomes from the population based South Australian Metastatic Colorectal Cancer Registry9
Clinical course of patients with renal cell carcinoma or urothelial carcinoma who had stable disease as an initial response to a PD‐1 or PD‐L1 inhibitor9
Treatment outcomes of patients with involved resection margin after rectal cancer surgery: A nationwide population‐based cohort study in South Korea9
Issue Information9
Hospitalizations in solid tumor phase I clinical trial patients: Incidence, pattern and clinical outcomes at an Australian phase I clinical trial unit9
Overdiagnosis and overtreatment of ground‐glass nodule‐like lung cancer8
8
Comparison of direct medical care costs between patients receiving care in a designated palliative care unit and the usual care units8
Differences in ultrasonographic features between males and females with breast cancer of the luminal A and luminal B molecular subtypes8
8
Phase 1 trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study)8
2021 COSA ASM Exhibitor Profiles7
NATIONAL SPEAKERS7
COSA President's Welcome7
AUTHOR INDEX7
Poster Abstracts7
2021 Hunter Cancer Research Symposium7
6
Issue Information6
Poster Abstracts6
6
Management of rectal cancer in the era of total neoadjuvant therapy and watch and wait: A multidisciplinary team discussion at the Australasian Gastro‐Intestinal Trials Group (AGITG) Annual Scientific6
Issue Information6
Invited speakers6
Consensus statements on the management of metastatic renal cell carcinoma from the Hong Kong Urological Association and the Hong Kong Society of Uro‐Oncology 20196
Resilience and ongoing quality care for cancer clinical trials during COVID‐19: Experience from a tertiary hospital in Australia6
International Presenters6
Suitability of endobronchial ultrasound‐guided transbronchial needle aspiration samples for programmed death ligand‐1 testing in non‐small cell lung cancer, the Bristol experience6
Rapid Fire presentation abstracts6
AUTHOR INDEX5
2023 COSA ASM Exhibitor Profiles5
Hong Kong Urological Association–Hong Kong Society of Uro‐Oncology consensus statements on the management of advanced prostate cancer—2019 Updates5
Clinical results of total en bloc spondylectomy using a single posterior approach in spinal metastasis patients: Experiences from Thailand5
Young Oncologist Oral Presentation Abstracts5
Comparison of weekly methotrexate regimen versus methotrexate folinic acid 8‐day regimen for treatment of low‐risk gestational trophoblastic neoplasia5
Malignant pericardial effusions: A retrospective look at etiology and prognosis in a tertiary oncological center5
ANZUP Chair Welcome5
Oral Abstracts5
Issue Information5
A prospective study of diagnostic accuracy of multidisciplinary team and radiology reporting of preoperative colorectal cancer local staging5
Issue Information5
An Australian mainstream genetic testing program: Clinicians views about current and future practices5
National Speakers5
5
If we build it, will they come? Modeling of public hospital care requirements for the Australian Bragg Centre for Proton Therapy and Research5
T‐cell lymphoma patient harboring BCL11B mutations had favorable overall survival5
Acknowledgements5
Maintenance chemotherapy in advanced and metastatic pancreatic cancer, a narrative review and case series5
Real‐world effectiveness of regorafenib in the treatment of patients with metastatic colorectal cancer: A retrospective, observational study4
Advancing ovarian cancer diagnosis: harnessing artificial intelligence and novel biomarker strategies4
Prevalence and risk factors of chemotherapy‐induced oral mucositis among adult cancer patients at the cancer unit of Mbarara Regional Referral Hospital4
Utilization of clinical practice guidelines for cancer care in routine practice and during the coronavirus disease 2019 pandemic in India4
Molecular Mechanisms of circKIF4A in Breast Cancer Progression4
miRNA‐31 increases radiosensitivity through targeting STK40 in colorectal cancer cells4
Nomogram based on the systemic immune‐inflammation index for predicting the prognosis of diffuse large B‐cell lymphoma4
A proposed framework for the implementation of head and neck cancer treatment at a new cancer center from a radiation oncology perspective4
The Effectiveness of Afatinib as First‐Line Treatment in Vietnamese Patients With EGFR‐Mutant Non–Small Cell Lung Cancer and Brain Metastases4
Author Index4
Association between financial toxicity and health‐related quality of life in cancer survivors: A systematic review4
The impact of coronavirus disease 2019 on genitourinary and prostate cancer care and clinical trials: A qualitative exploration of the Australian and New Zealand experience4
Centralization and prospective audit of cystectomy are necessary: a commentary on the case for centralization, supported by a contemporary series utilizing the ANZUP cystectomy database4
Neoadjuvant Chemotherapy With Chemoradiotherapy for Patients With Borderline Resectable or Locally Advanced Pancreatic Ductal Adenocarcinoma— Retrospective Review From a Tertiary Care Hospital4
Associations of body mass index and weight change with circulating levels of high‐sensitivity C‐reactive protein, proinflammatory cytokines, and adiponectin among breast cancer survivors4
“Artificial Intelligence in NAFLD Diagnosis: A New Frontier in Managing Metastatic Prostate Cancer Risk”3
Survival analysis for older patients with epidermal growth factor receptor mutation‐positive advanced non‐small cell lung cancer after progression of first‐line gefitinib3
Prevention and management of acneiform rash associated with EGFR inhibitor therapy: A systematic review and meta‐analysis3
3
Loss of CDX‐2 expression is an independent poor prognostic biomarker in patients with early‐stage deficient mismatch repair colorectal cancer3
Safety and potential increased risk of toxicity of radiotherapy combined immunotherapy strategy3
COSA COMMITTEES3
Cyclophosphamide‐induced cardiotoxicity at conditioning for allogeneic hematopoietic stem cell transplantation would occur among the patients treated with 120 mg/kg or less3
3
The prognostic significance of immune checkpoint receptor expression in patients with lymphoma: Association with disease status and clinical outcomes3
Incidence and risk factors for neoplasia in inflammatory bowel disease3
Referral and uptake of services by distressed callers to the Cancer Council Information and Support telephone service3
Issue Information3
Trainee Oral Presentation Abstracts3
Molecular basis and targeted therapies for radioiodine refractory thyroid cancer3
Perceived importance of emotional support provided by health care professionals and social networks: Should we broaden our focus for the delivery of supportive care?3
Corrigendum3
Prevention of docetaxel‐associated febrile neutropenia with primary granulocyte colony‐stimulating factor in Chinese metastatic hormone‐sensitive and castration‐resistant prostate cancer patients3
Exercise recommendations and referral patterns of oncology professionals3
Issue Information3
Upregulation of O‐GlcNAc transferase is involved in the pathogenesis of acute myeloid leukemia3
Life‐threatening infections during treatment for acute lymphoblastic leukemia on the Malaysia‐Singapore 2003 and 2010 clinical trials: A risk prediction model3
Established the prediction model of early‐stage non‐small cell lung cancer spread through air spaces (STAS) by radiomics and genomics features3
The Case for Shared Decision‐making in Oncology and Why the Philippine Healthcare System is Primed for It3
The role of surveillance imaging for resected high‐risk melanoma3
Adjuvant Radiotherapy After Surgical Resection Improves Local Control in Adrenocortical Carcinoma3
Impact of Antibiotics and Chronic Medications on Efficacy of Immune Checkpoint Inhibitors in Patients With Hepatocellular Carcinoma3
The impact of multidisciplinary cancer meetings in guiding treatment intent in patients with upper tract urothelial carcinoma3
Transcription factor KLF9 inhibits the proliferation, invasion, and migration of pancreatic cancer cells by repressing KIAA15223
The molecular characteristics of non‐small cell lung cancer in the Northern Territory's Top End3
Olaparib dose re‐escalation in ovarian cancer patients who experienced severe and/or uncommon adverse events: A case series3
Fremantle protocol: Multicenter clinical outcomes for a pragmatic protocol for intravesical bacillus Calmette–Guerin3
A smartphone program to support adherence to oral chemotherapy in people with cancer: Proof‐of‐concept trial3
COSA President's Welcome3
Real‐world data on efficacy and safety of osimertinib in non‐small cell lung cancer patients with EGFR T790M mutation detected by first and repeat rebiopsy3
Antithrombotic drug use does not affect the fecal immunochemical test PPV for colorectal cancer, but warfarin may have an impact in a Japanese cohort3
The therapeutic effects of berberine for gastrointestinal cancers3
Effect of diabetes mellitus comorbidity on outcomes in stages II and III colorectal cancer3
TYK2 is a prognostic biomarker and associated with immune infiltration in the lung adenocarcinoma microenvironment3
Cancer stem cell biomarkers SOX2 and Oct4 in cervical cancer patients undergoing chemoradiotherapy2
2
Telehealth adoption in cancer clinical trials: An Australian perspective2
Sponsor Acknowledgments2
Drug‐eluting bead transarterial chemoembolization with medium‐sized versus small‐sized CalliSpheres microspheres in unresectable primary liver cancer2
Construction and validation of a novel tumor necrosis factor‐related apoptosis‐inducing ligand mutant MuR5S4‐TR2
2
A novel exosome‐related prognostic risk model for thyroid cancer2
International Speakers2
Organising Committee2
Poster Abstracts2
2
Awards and Scholarships2
2
2
Real‐world management and patient perspectives on QOL with neuroendocrine tumors: An ANZ perspective2
A feasibility study of modified docetaxel, cisplatin, and capecitabine for advanced gastric cancer followed by gastrectomy2
Clinical outcomes and prognostic factors of cone‐beam CT‐guided radiofrequency ablation for pulmonary metastases in colorectal cancer patients2
2
Pneumocystis jirovecii Pneumonia in Cancer Patients, a Lethal Yet Fully Preventable Disease: Insights From a Tertiary Cancer Center in East India2
Treatment patterns and long‐term survival outcomes for patients with stage III non‐small cell lung cancer: A retrospective study2
A risk factor analysis for local recurrence of bone and soft tissue sarcoma treated with carbon ion radiotherapy: A retrospective cohort study at a single institution2
2023 COSA ASM Exhibitor Listing2
International speakers2
Different characteristics of the tumor immune microenvironment among subtypes of salivary gland cancer2
Issue Information2
Encapsulated papillary carcinoma of the breast clinicopathological features and management: Could sentinel lymph node biopsy be exempted?2
Sponsor Acknowledgements2
Immune checkpoint inhibitors and tyrosine kinase inhibitors in patients with advanced hepatocellular carcinoma: Does the sequence matter?2
2
2023 ANZUP Annual Scientific Meeting, 9‐11 July 2023, Melbourne Convention Centre, Victoria, Australia2
2
Less aggressive treatment for less aggressive disease? A retrospective single‐center study of pulmonary‐limited metastases associated with colorectal cancer2
Issue Information2
Screening for viral hepatitis B infection in cancer patients before receiving chemotherapy – A systematic review and meta‐analysis2
Impact of age on outcomes in young women with breast cancer2
Issue Information2
Issue Information2
Oral presentation abstracts2
Program in Detail2
Management of advanced prostate cancer in the Asia‐Pacific region: Summary of the Asia‐Pacific Advanced Prostate Cancer Consensus Conference 20232
Incidence and appropriate management of drug‐induced interstitial lung disease in Japanese patients with unresectable pancreatic cancer: A multicenter retrospective study2
Participation in oral health screening among cancer survivors2
E74‐like factor 4 promotes the proliferation, invasion, and migration of colorectal cancer cells via long non‐coding RNA integrin subunit beta 8 antisense RNA 1‐mediated histone H3 lysine 27 trimethyl2
Does the number of cycles of neoadjuvant therapy affect the efficacy of neoadjuvant chemoimmunotherapy for non‐small cell lung cancer in locally advanced stage? Retrospective experience based on a sin2
Safety and efficacy of high‐dose cytarabine MEAM therapy and other treatments for auto‐peripheral blood stem cell transplantation: A retrospective comparative study2
Clinical application of preserving spontaneous breathing non‐intubation anesthesia in thoracoscopic surgery for lung cancer under ERAS concept2
Cost‐effectiveness analysis of human papillomavirus vaccines for the prevention of cervical cancer in India2
List of Poster Abstracts2
Radioimmunotherapy with 131I‐rituximab for patients with relapsed or refractory follicular or mantle cell lymphoma2
ANZUP Chair Welcome2
Issue Information2
Toxicity profile of patients treated with proton and carbon‐ion therapy for primary nasopharyngeal carcinoma: A systematic review and meta‐analysis2
Esophageal chemoradiotherapy with concurrent nivolumab: Pilot results in the palliative treatment of oligometastatic disease2
PD‐L1 heterogeneity in patients with non–small cell lung cancer2
0.19220590591431